V356 Complaint and adverse reaction records
Written V0356 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR 494.50(b)(1)
13.2.3 Recording
Any significant events such as the occurrence of symptoms listed in [AAMI] 13.2.1 and 13.2.2 should be recorded on an incident report form which would include the results of the evaluations conducted by the physician and others[, and] the event should be considered for reporting to the manufacturer(s) in accordance with the FDA’s Medical Device User Reporting procedures. The resolution of actual or suspected problems caused by reprocessed dialyzers should be indicated. This report should be kept in the complaint investigation record file (see [AAMI] 4.5).
4 Records
4.5 Complaint investigation record
Records shall be kept of all complaints by patients and staff members about failures of preprocessed and reprocessed dialyzers or possible adverse reactions to any dialyzers; the results of a comprehensive investigation of these alleged problems; and, if appropriate, the corrective actions taken. The records shall be reviewed periodically for trends of adverse reactions. . . Compliance with the FDA’s Medical Device User Reporting procedures [shall be demonstrated.]
CMS's interpretive guidance
Interpretive Guidance § 494.50(b)(1)
In dialyzer reprocessing, the term “complaint” refers to deviations from expected outcomes (e.g. dialyzer failures, patient reactions, blood leaks), as well as to patient complaints related to reused dialyzers.
The facility must maintain a record of dialyzer complaints. Each complaint should be investigated, and any reuse incidents reported in the QAPI records with corrective actions as indicated.
Responsible staff (e.g., the chief technician, area technical manager, nurse administrator, medical director) should consider if there have been any trends in complaints, and take indicated action. This information should be incorporated into the facility’s QAPI program. Refer to V635.
Facility staff must comply with the FDA’s Medical Device User Reporting requirements. Refer to V383.
https://middlemolecule.com/rulebook/tags/v356/